Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Redox Status of Erythrocytes as an Important Factor in Eryptosis and Erythronecroptosis

A. Tkachenko, O. Havránek

. 2023 ; 69 (4) : 116-126. [pub] -

Language English Country Czech Republic

Document type Journal Article

Grant support
PRIMUS/17/ MED/9 Univerzita Karlova v Praze
UNCE/MED/016 Univerzita Karlova v Praze

Overall, reactive oxygen species (ROS) signalling significantly contributes to initiation and mo-dulation of multiple regulated cell death (RCD) pathways. Lately, more information has become available about RCD modalities of erythrocytes, including the role of ROS. ROS accumulation has therefore been increasingly recognized as a critical factor involved in eryptosis (apoptosis of erythrocytes) and erythro-necroptosis (necroptosis of erythrocytes). Eryptosis is a Ca2+-dependent apoptosis-like RCD of erythrocytes that occurs in response to oxidative stress, hyperosmolarity, ATP depletion, and a wide range of xenobiotics. Moreover, eryptosis seems to be involved in the pathogenesis of multiple human diseases and pathological processes. Several studies have reported that erythrocytes can also undergo necroptosis, a lytic RIPK1/RIPK3/MLKL-mediated RCD. As an example, erythronecroptosis can occur in response to CD59-specific pore-forming toxins. We have systematically summarized available studies regarding the involvement of ROS and oxidative stress in these two distinct RCDs of erythrocytes. We have focused specifically on cellular signalling pathways involved in ROS-mediated cell death decisions in erythrocytes. Furthermore, we have summarized dysregulation of related erythrocytic antioxidant defence systems. The general concept of the ROS role in eryptotic and necroptotic cell death pathways in erythrocytes seems to be established. However, further studies are required to uncover the complex role of ROS in the crosstalk and interplay between the survival and RCDs of erythrocytes.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24003875
003      
CZ-PrNML
005      
20250120125638.0
007      
ta
008      
240305s2023 xr a f 000 0|eng||
009      
AR
024    7_
$a 10.14712/fb2023069040116 $2 doi
035    __
$a (PubMed)38410969
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Tkachenko, Anton $u BIOCEV, First Faculty of Medicine, Charles University, Vestec, Czech Republic $7 xx0328071
245    10
$a Redox Status of Erythrocytes as an Important Factor in Eryptosis and Erythronecroptosis / $c A. Tkachenko, O. Havránek
520    9_
$a Overall, reactive oxygen species (ROS) signalling significantly contributes to initiation and mo-dulation of multiple regulated cell death (RCD) pathways. Lately, more information has become available about RCD modalities of erythrocytes, including the role of ROS. ROS accumulation has therefore been increasingly recognized as a critical factor involved in eryptosis (apoptosis of erythrocytes) and erythro-necroptosis (necroptosis of erythrocytes). Eryptosis is a Ca2+-dependent apoptosis-like RCD of erythrocytes that occurs in response to oxidative stress, hyperosmolarity, ATP depletion, and a wide range of xenobiotics. Moreover, eryptosis seems to be involved in the pathogenesis of multiple human diseases and pathological processes. Several studies have reported that erythrocytes can also undergo necroptosis, a lytic RIPK1/RIPK3/MLKL-mediated RCD. As an example, erythronecroptosis can occur in response to CD59-specific pore-forming toxins. We have systematically summarized available studies regarding the involvement of ROS and oxidative stress in these two distinct RCDs of erythrocytes. We have focused specifically on cellular signalling pathways involved in ROS-mediated cell death decisions in erythrocytes. Furthermore, we have summarized dysregulation of related erythrocytic antioxidant defence systems. The general concept of the ROS role in eryptotic and necroptotic cell death pathways in erythrocytes seems to be established. However, further studies are required to uncover the complex role of ROS in the crosstalk and interplay between the survival and RCDs of erythrocytes.
650    _2
$a lidé $7 D006801
650    12
$a eryptóza $x fyziologie $7 D000072817
650    _2
$a reaktivní formy kyslíku $x metabolismus $7 D017382
650    _2
$a vápník $x metabolismus $7 D002118
650    _2
$a erytrocyty $x metabolismus $7 D004912
650    _2
$a oxidace-redukce $7 D010084
655    _2
$a časopisecké články $7 D016428
700    1_
$a Havránek, Ondřej $u 1st Department of Medicine - Department of Haematology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic. ondrej.havranek@lf1.cuni.cz $u BIOCEV, First Faculty of Medicine, Charles University, Vestec, Czech Republic. ondrej.havranek@lf1.cuni.cz $7 xx0128548
773    0_
$w MED00011004 $t Folia biologica $x 0015-5500 $g Roč. 69, č. 4 (2023), s. 116-126
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38410969 $y Pubmed
910    __
$a ABA008 $b A 970 $c 89 $y p $z 0
990    __
$a 20240305 $b ABA008
991    __
$a 20250120125636 $b ABA008
999    __
$a ok $b bmc $g 2247157 $s 1213627
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 69 $c 4 $d 116-126 $e - $i 0015-5500 $m Folia biologica $n Folia Biol (Praha) $x MED00011004
GRA    __
$a PRIMUS/17/ MED/9 $p Univerzita Karlova v Praze
GRA    __
$a UNCE/MED/016 $p Univerzita Karlova v Praze
LZP    __
$b NLK138 $a Pubmed-20240305

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...